E
NeuroPace, Inc. NPCE
$10.42 -$0.22-2.07%
Recommendation
Sell
Prev Close
$10.64
Volume
102,130
Avg Vol (90D)
193,813
Market Cap
$346.44M
Dividend & Yield
--
52-Week Range
$5.45 - $15.11
P/E (TTM)
--
EPS (TTM)
-$0.9411
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
D
Weak
Rating Factors
Growth Index
Fair
Efficiency Index
Very Weak
Solvency Index
Good
Total Return Index
Fair
Volatility Index
Weak
Dividend Index
--
Headlines
Neuropace (NPCE, $10.64) Aroon Indicator entered an Uptrend on April 10, 2025.
4/11/2025 - Tickeron - Stocks
Neuropace (NPCE, $11.67) Aroon Indicator entered an Uptrend on April 09, 2025.
4/10/2025 - Tickeron - Stocks
Neuropace (NPCE, $11.1) Aroon Indicator entered an Uptrend on April 08, 2025.
4/9/2025 - Tickeron - Technical Analysis
Neuropace (NPCE, $11.1) Moving Average Convergence Divergence (MACD) Histogram turned negative on April 8, 2025
4/9/2025 - Tickeron - Technical Analysis
Neuropace (NPCE, $11.1) entered Downtrend as Momentum indicator drops below 0 level on Apr 08, 2025
4/9/2025 - Tickeron - Technical Analysis
NeuroPace Announces Data From a Long-Term Post-Approval Study of the RNS System in Focal ...
4/8/2025 - GuruFocus
NeuroPace announces data from long-term post-approval study of RNS System
4/8/2025 - The Fly
NeuroPace Announces Data From a Long-Term Post-Approval Study of the RNS System in Focal Epilepsy at the 2025 AAN Annual Meeting
4/8/2025 - Globe Newswire
Q1 Earnings Estimate for NeuroPace Issued By Leerink Partnrs
4/8/2025 - MarketBeat
Neuropace (NPCE, $12.23) price exceeded its 50-day Moving Average on April 04, 2025
4/5/2025 - Tickeron - Technical Analysis
NeuroPace, Inc. (NASDAQ:NPCE) Short Interest Update
4/3/2025 - MarketBeat
NeuroPace Announces Upcoming Oral Presentation of Data from the Long-Term Post-Approval Study ...
4/3/2025 - GuruFocus
NeuroPace Announces Upcoming Oral Presentation of Data from the Long-Term Post-Approval Study of the RNS System at the 2025 AAN Annual Meeting
4/3/2025 - Globe Newswire
Neuropace (NPCE, $13.54) price may drop as it broke higher Bollinger Band on Apr 02, 2025
4/3/2025 - Tickeron - Stocks
NeuroPace Announces Refocusing of Product Portfolio
4/2/2025 - GuruFocus
NeuroPace Shifts Focus to Core RNS System
4/2/2025 - TipRanks Financial Blog
NeuroPace refocuses product portfolio; reaffirms 2025 revenue guidance
4/2/2025 - Seeking Alpha - Healthcare
NeuroPace to terminate distribution relationship for Seeg products
4/2/2025 - The Fly
NeuroPace Announces Refocusing of Product Portfolio
4/2/2025 - Globe Newswire
Neuropace (NPCE, $13.11) price moved above its 50-day Moving Average on April 01, 2025
4/2/2025 - Tickeron - Stocks
NeuroPace (NASDAQ:NPCE) Stock Price Down 4.3% - What's Next?
3/30/2025 - MarketBeat
Neuropace (NPCE, $12.38) price exceeded its 50-day Moving Average on March 27, 2025
3/28/2025 - Tickeron - Stocks
NeuroPace Inc (NPCE) Stock Price Down 4.25% on Mar 27
3/27/2025 - GuruFocus
Look Under The Hood: VTHR Has 22% Upside
3/27/2025 - ETF Channel
Neuropace (NPCE, $12.72) price moved above its 50-day Moving Average on March 26, 2025
3/27/2025 - Tickeron - Stocks
Income Statement
Total Revenue (TTM)
$79.91M
EBITDA (TTM)
-$21.46M
EBIT (TTM)
-$21.67M
Net Income (TTM)
-$27.14M
Balance Sheet
Total Assets (Q)
$94.65M
Total Debt (Q)
$73.34M
Total Liabilities (Q)
$86.63M
Book Value Per Share (Q)
$0.2658
Cash Flow
Cash from Operations (TTM)
-$17.95M
Cash from Investing (TTM)
$8.99M
Cash from Financing (TTM)
$4.33M
Net Change in Cash (TTM)
-$4.63M
Filings
Filing Date
Tuesday, March 4, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Loading...
Beta
0.69
7-Day Total Return
-23.04%
30-Day Total Return
-19.54%
60-Day Total Return
-13.17%
90-Day Total Return
-1.70%
Year to Date Total Return
-10.02%
1-Year Total Return
-28.16%
2-Year Total Return
126.52%
3-Year Total Return
32.07%
5-Year Total Return
--
52-week Low
Oct 25, 2024 - $5.45
52-week High
Jan 24, 2025 - $15.11
Valuation
Market Cap
$346.44M - Small Cap
Enterprise Value
$367.02M
Price/Sales (TTM)
3.98
Price/Book (Q)
40.03
Dividends and Shares
Shares Outstanding
29.91M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.neuropace.com
Phone Number
(650) 237-2700
Address
455 North Bernardo Avenue
Mountain View, CA 94043
Country
United States
Year Founded
1997
Business Description
Sector
Health Care
Industry
Health Care Equipment and Services
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time... more
NASDAQ 04/11/2025 4:00PM Eastern Quotes delayed
Weiss Ratings